↓ Skip to main content

CAR T-Cell Therapy for B-Cell non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Clinical Trials and Real-World Experiences

Overview of attention for article published in Frontiers in oncology, May 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
73 Dimensions

Readers on

mendeley
130 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CAR T-Cell Therapy for B-Cell non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Clinical Trials and Real-World Experiences
Published in
Frontiers in oncology, May 2020
DOI 10.3389/fonc.2020.00849
Pubmed ID
Authors

Candida Vitale, Paolo Strati

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 130 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 130 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 12%
Student > Master 14 11%
Student > Doctoral Student 11 8%
Student > Bachelor 11 8%
Other 9 7%
Other 19 15%
Unknown 51 39%
Readers by discipline Count As %
Medicine and Dentistry 31 24%
Biochemistry, Genetics and Molecular Biology 12 9%
Immunology and Microbiology 10 8%
Pharmacology, Toxicology and Pharmaceutical Science 6 5%
Engineering 4 3%
Other 12 9%
Unknown 55 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 July 2020.
All research outputs
#15,425,537
of 26,158,673 outputs
Outputs from Frontiers in oncology
#4,322
of 22,910 outputs
Outputs of similar age
#223,855
of 433,090 outputs
Outputs of similar age from Frontiers in oncology
#110
of 482 outputs
Altmetric has tracked 26,158,673 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,910 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,090 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 482 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.